Waxing Lyrica: Big Pharma Subverts the Patent Process
This December, the patent for Pfizer’s goldmine drug Lyrica will expire. Lyrica is prescribed for neuropathic illnesses such as epilepsy and fibromyalgia. Since its approval in 2004, Lyrica has made billions for Pfizer: in only three of its 14 years of sales, Lyrica sold over $10 billion worth of this drug. (Pfizer’s total revenue for …